Identification of a novel WT1‐derived peptide which induces human leucocyte antigen‐A24‐restricted anti‐leukaemia cytotoxic T lymphocytes

This publication has 14 references indexed in Scilit:

• Identification of human telomerase reverse transcriptase–derived peptides that induce HLA-A24–restricted antileukemia cytotoxic T lymphocytes
  Blood, 2001
• Quantitative monitoring of the PRAME gene for the detection of minimal residual disease in leukaemia
  British Journal of Haematology, 2001
• Selective elimination of leukemic CD34+ progenitor cells by cytotoxic T lymphocytes specific for WT1
  Blood, 2000
• Human cytotoxic T-lymphocyte responses specific for peptides of the wild-type Wilms' tumor gene ( WT1 ) product
  Immunogenetics, 2000
• HLA class I-restricted lysis of leukemia cells by a CD8+ cytotoxic T-lymphocyte clone specific for WT1 peptide
  Blood, 2000
• The Telomerase Catalytic Subunit Is a Widely Expressed Tumor-Associated Antigen Recognized by Cytotoxic T Lymphocytes
  Immunity, 1999
• Expression of the Wilms' Tumor Gene WT1 in Solid Tumors and Its Involvement in Tumor Cell Growth
  Japanese Journal of Cancer Research, 1999
• Cytotoxic T cell response against the chimeric ETV6-AML1 protein in childhood acute lymphoblastic leukemia.
  Journal of Clinical Investigation, 1998
• Dendritic Cells Stimulate the Expansion of bcr-abl Specific CD8+ T Cells With Cytotoxic Activity Against Leukemic Cells From Patients With Chronic Myeloid Leukemia
  Blood, 1998
• Targeted T-cell therapy for human leukemia: cytotoxic T lymphocytes specific for a peptide derived from proteinase 3 preferentially lyse human myeloid leukemia cells
  Blood, 1996